These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19273265)

  • 1. Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure.
    Anilkumar N; Sirker A; Shah AM
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):3168-87. PubMed ID: 19273265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
    Murdoch CE; Zhang M; Cave AC; Shah AM
    Cardiovasc Res; 2006 Jul; 71(2):208-15. PubMed ID: 16631149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
    Sirker A; Zhang M; Murdoch C; Shah AM
    Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox regulation of cardiac hypertrophy.
    Sag CM; Santos CX; Shah AM
    J Mol Cell Cardiol; 2014 Aug; 73():103-11. PubMed ID: 24530760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications.
    Nediani C; Raimondi L; Borchi E; Cerbai E
    Antioxid Redox Signal; 2011 Jan; 14(2):289-331. PubMed ID: 20624031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of oxidative stress in heart failure].
    Gál R; Halmosi R
    Orv Hetil; 2015 Nov; 156(47):1916-20. PubMed ID: 26568107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and heart failure.
    Byrne JA; Grieve DJ; Cave AC; Shah AM
    Arch Mal Coeur Vaiss; 2003 Mar; 96(3):214-21. PubMed ID: 12722552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidases and cardiac remodelling.
    Nabeebaccus A; Zhang M; Shah AM
    Heart Fail Rev; 2011 Jan; 16(1):5-12. PubMed ID: 20658317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.
    Seddon M; Looi YH; Shah AM
    Heart; 2007 Aug; 93(8):903-7. PubMed ID: 16670100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox modification of caveolar proteins in the cardiovascular system- role in cellular signalling and disease.
    Bubb KJ; Birgisdottir AB; Tang O; Hansen T; Figtree GA
    Free Radic Biol Med; 2017 Aug; 109():61-74. PubMed ID: 28188926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox signaling in cardiac physiology and pathology.
    Burgoyne JR; Mongue-Din H; Eaton P; Shah AM
    Circ Res; 2012 Sep; 111(8):1091-106. PubMed ID: 23023511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CyPA in cardiac hypertrophy and remodeling.
    Cao M; Yuan W; Peng M; Mao Z; Zhao Q; Sun X; Yan J
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31825469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase and cardiac failure.
    Kuroda J; Sadoshima J
    J Cardiovasc Transl Res; 2010 Aug; 3(4):314-20. PubMed ID: 20559780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel aspects of ROS signalling in heart failure.
    Hafstad AD; Nabeebaccus AA; Shah AM
    Basic Res Cardiol; 2013 Jul; 108(4):359. PubMed ID: 23740217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox signaling in the cardiomyocyte: From physiology to failure.
    Santos CX; Raza S; Shah AM
    Int J Biochem Cell Biol; 2016 May; 74():145-51. PubMed ID: 26987585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Wilson AJ; Gill EK; Abudalo RA; Edgar KS; Watson CJ; Grieve DJ
    Heart; 2018 Feb; 104(4):293-299. PubMed ID: 28954833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in Cardiac Hypertrophy.
    Wehbe N; Nasser SA; Pintus G; Badran A; Eid AH; Baydoun E
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.
    Sorescu D; Griendling KK
    Congest Heart Fail; 2002; 8(3):132-40. PubMed ID: 12045381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
    Koga K; Kenessey A; Ojamaa K
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.